Triiodothyronine (T3), Reverse
Triiodothyronine (T3) is a thyroid hormone produced mainly from peripheral (liver and some other organs) conversion of thyroxine (T4), a prohormone. The T3 test is typically ordered to determine the functionality of the thyroid. T4 levels are much greater than T3 but T3 has greater biological activity than T4 and is considered the metabolically active form of thyroid hormone, although its effect is briefer than T4. T3 binds less tightly than T4 to thyroid binding globulin by a factor of about 10, and has about a 15 x greater affinity for thyroid receptor. Generally, thyroid hormones exist in human plasma as free and bound forms, for example free T3 and free T4 as well as bound T3 and bound T4. Total T3 measures both bound and unbound T3. Less than 1% (approximately 0.3% for T3) is in the free form. Serum concentration of the free forms of total serum T3 and T4 are regulated by feedback systems (cellular uptake). Thus the free hormone fraction determines the thyroid status of the individual. Bound fractions are unavailable to exert metabolic effect, because binding to their transport protein makes it unavailable to the receptor. In addition to TBG there are other proteins that bind T3, such as transthyretin and albumin.
A reduction in conversion of T4 to T3 results in a decreased T3 concentration. Reduced total T3 levels occur in drug therapy with androgens, prednisone, dexamethasone, and glucocorticoids. T3 levels are also reduced in iodine deficiency, non-thyroidal diseases also known as low T3 syndrome, anorexia nervosa, and following surgery to remove the thyroid gland. Increased T3 often occurs in hyperthyroidism known as T3 toxicosis. In T3 toxicosis T3 values are high while total or free thyroxine (T4 and FT4) are normal and TSH is low.
- In diagnosis of T3 hyperthyroidism with normal T4 and low TSH
- As an aid in diagnosis of thyrotoxicosis such as that in Graves Disease
- As an aid in confirmation of the diagnosis of conventional hyperthyroidism in which both serum T3 and T4 are increased
Increased in:
- Hyperthyroidism
- T3 thyrotoxicosis
- Peripheral resistance syndrome
- Treated hyperthyroidism
- Early thyroid failure
- Iodine deficiency goiter
- Conditions with elevated levels of thyroid-binding globulin
- Thyrotoxicosis factitia
- Pregnancy
Decreased in:
- Hypothyroidism
- Acute and subacute nonthyroidal illness
- Conditions with decreased thyroid-binding globulin
- Decreased in use of some drugs: amiodarone, corticosteroids, androgens, dexamethasone
- Anorexia nervosa
- Malnutrition
| Age / Condition | ng/dL | nmol/L |
| Cord (>37 wk) | 5–141 | 0.08–2.17 |
| 1–3 days | 100–740 | 1.54–11.40 |
| 1–11 mo | 105–245 | 1.62–3.77 |
| 1–5 yr | 105–269 | 1.62–4.14 |
| 6–10 yr | 94–241 | 1.45–3.71 |
| 11–15 yr | 82–213 | 1.26–3.28 |
| 16–20 yr | 80–210 | 1.23–3.23 |
| Adult 20–50 yr | 70–204 | 1.08–3.11 |
| 50–90 yr | 40–181 | 0.62–2.79 |
| Pregnancy (last 5 mo) | 116–247 | 1.79–3.80 |
Serum (SST) or plasma (EDTA).
Stability
- Ambient: 3-5 days
- Refrigerated: 5-7 days
- Frozen: 30 days
- Lancet. 2001;357:619. [PMID: 11558500]
- Clin Lab Med. 1993 Sep;13(3):653-72. [PMID: 8222580]
- Am Fam Physician. 2005;72:1517. [PMID: 16273818]
- Horm Res. 1996;45(3-5):142-7. [PMID: 8964573]
- Endocrinol Metab Clin North Am. 2007 Sep;36(3):579-94, v. [PMID: 17673120]
- Clin Chem. 2005;51:1480. [PMID: 15961550]
- Clin Lab Med. 1993 Sep;13(3):599-630. [PMID: 8222577]
- Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757